{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "G",
            "alt": "A",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "46"
          },
          "Description in input context": "E46K"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0000073"
  },
  "Experiment Method": [
    {
      "Assay Method": "Ganglioside-binding assay",
      "Material used": {
        "Material Source": "Synthetic peptides",
        "Material Name": "GBD peptides",
        "Description": "Synthetic GBD peptides were used to assess binding to glycosphingolipids."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "N.D.",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Amino acid substitution",
          "Result Description": "E46K mutation enhanced binding to GM3 compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": 0
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": 0
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein interaction > 50% of wild-type",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein interaction < 20% of wild-type",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "No"
      }
    },
    {
      "Assay Method": "Channel formation assay",
      "Material used": {
        "Material Source": "Reconstituted bilayers",
        "Material Name": "Phosphatidylcholine bilayers",
        "Description": "Reconstituted phosphatidylcholine bilayers were used to measure ion channel activity."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "N.D.",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Amino acid substitution",
          "Result Description": "E46K mutation increased channel conductance by 30% compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": 0
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": 0
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Channel conductance < 10 pS",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Channel conductance > 15 pS",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "No"
      }
    },
    {
      "Assay Method": "Alanine substitution analysis",
      "Material used": {
        "Material Source": "Synthetic peptides",
        "Material Name": "Alanine-substituted GBD peptides",
        "Description": "Alanine substitutions were introduced to assess functional roles of specific residues."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "N.D.",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Amino acid substitution",
          "Result Description": "Alanine substitutions at residues 46 reduced GM3 binding by 50%."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": 0
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": 0
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Binding > 70% of wild-type",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Binding < 30% of wild-type",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "No"
      }
    }
  ]
}